A randomised controlled trial of intravenous steroids at home versus outpatients department for treatment of acute multiple sclerosis relapses

Completed (inferred)MS (type not specified)ISRCTN95588376

What it found

Paper found, not read

A paper reports the results; we have not read it yet. See Papers below.

What it measured

Main measures

  • Patient and carer perception of management of MS relapse.

    Relapses

Other measures (1)

  • Other measures include patients' safety, MS impact scores and cost of health case resources.

    Safety

Who could take part

MS (type not specified)

Show the full criteria

Inclusion criteria

Inclusion: 164 Patients from Neurology. Exclusion: Not provided at time of registration

Exclusion criteria

Not separately supplied in the registry.

As registered. Criteria can change, so ask the trial team or your neurologist.

About this trial

In the sponsor's words

Not provided at time of registration

Papers

Loading reviews and guidelines…

History

    1. Started

      Sept 2002

    2. Finished

      Dec 2006

    Assembled by software from public sources.